We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+13.99%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.33B
AUM Growth
+$796M
Cap. Flow
-$12M
Cap. Flow %
-0.16%
Top 10 Hldgs %
60.07%
Holding
377
New
123
Increased
61
Reduced
77
Closed
82

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$68.6M
2
ARGX icon
argenx
ARGX
+$55M
3
SNY icon
Sanofi
SNY
+$50.7M
4
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$50.5M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$42.3M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$48.6M
2
KDP icon
Keurig Dr Pepper
KDP
+$45.5M
3
INCY icon
Incyte
INCY
+$45.2M
4
UNH icon
UnitedHealth
UNH
+$37.3M
5
CPB icon
Campbell Soup
CPB
+$32M

Sector Composition

Rank Sector Weight
1 Healthcare 34.97%
2 Consumer Staples 5.35%
3 Consumer Discretionary 4.92%
4 Technology 3.86%
5 Communication Services 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
26
Biogen
BIIB
$29.8B
$51.8M 0.71%
200,000
-76,788
-28% -$18.9M
SNY icon
27
Sanofi
SNY
$103B
$51.5M 0.7%
+1,036,000
New +$50.7M
MDT icon
28
Medtronic
MDT
$111B
$50.1M 0.68%
608,000
-63,407
-9% -$4.83M
OFIX icon
29
Orthofix Medical
OFIX
$496M
$48.5M 0.66%
3,600,000
+636,000
+21% +$7.47M
MGNX icon
30
MacroGenics
MGNX
$243M
$44M 0.6%
4,572,000
-140,000
-3% -$968K
CL icon
31
Colgate-Palmolive
CL
$71.9B
$43M 0.59%
539,463
-422,537
-44% -$31.8M
NVO
32
Novo Nordisk
NVO
$208B
$41M 0.56%
396,000
-40,000
-9% -$3.96M
POST icon
33
Post Holdings
POST
$4.09B
$40.6M 0.55%
461,377
-72,257
-14% -$6.13M
VRTX icon
34
Vertex Pharmaceuticals
VRTX
$119B
$39.9M 0.54%
98,000
-18,117
-16% -$6.69M
TMCI icon
35
Treace Medical Concepts
TMCI
$304M
$36.4M 0.5%
+2,856,000
New +$28.9M
VYGR icon
36
Voyager Therapeutics
VYGR
$181M
$35.8M 0.49%
4,236,000
+58,000
+1% +$421K
DOCU
37
DocuSign
DOCU
$10.5B
$33.8M 0.46%
568,000
-135,147
-19% -$6.2M
ALKS icon
38
Alkermes
ALKS
$8.31B
$33.3M 0.45%
1,200,000
-696,775
-37% -$18.1M
K
39
DELISTED
Kellanova
K
$32.7M 0.45%
585,000
+580,526
+12,976% +$30.3M
KHC icon
40
Kraft Heinz
KHC
$31.3B
$32.4M 0.44%
875,556
-415,452
-32% -$14.1M
KURA icon
41
Kura Oncology
KURA
$816M
$32M 0.44%
2,224,000
-12,000
-0.5% -$118K
XNCR icon
42
Xencor
XNCR
$1.44B
$31.8M 0.43%
1,500,000
+22,000
+1% +$419K
STZ icon
43
Constellation Brands
STZ
$22.4B
$30.9M 0.42%
+127,868
New +$30.4M
TOST icon
44
Toast
TOST
$19B
$30.3M 0.41%
1,662,070
+424,711
+34% +$6.96M
MRTX
45
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$29.4M 0.4%
500,000
-864,098
-63% -$48.6M
TXRH icon
46
Texas Roadhouse
TXRH
$13.8B
$28.7M 0.39%
+235,000
New +$25.1M
SN icon
47
SharkNinja
SN
$22.7B
$28.4M 0.39%
555,012
+228,012
+70% +$10.4M
BCYC
48
Bicycle Therapeutics
BCYC
$270M
$27.8M 0.38%
1,536,000
+536,000
+54% +$8.87M
SBUX icon
49
Starbucks
SBUX
$118B
$26.7M 0.37%
+278,467
New +$27.1M
UNH icon
50
UnitedHealth
UNH
$377B
$26.3M 0.36%
50,000
-70,000
-58% -$37.3M
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Armistice Capital held 377 positions worth $7.33B, up 12% from $6.53B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Armistice Capital's Q4 2023 filing shows 123 new, 61 increased, 77 reduced and 82 closed positions. Its largest new stake was Sanofi: 1,036,000 shares worth $51.5M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $48.6M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q4 2023 buy was Sanofi: 1,036,000 shares worth $51.5M.
  • Armistice Capital added most to GSK in Q4 2023, an estimated $68.6M increase.
  • Armistice Capital's biggest Q4 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $48.6M.
  • Armistice Capital fully exited Keurig Dr Pepper in Q4 2023, selling an estimated $45.5M.
  • Armistice Capital's ten largest holdings make up 60% of its $7.33B portfolio in Q4 2023.
  • Armistice Capital opened 123 new positions and closed 82 in Q4 2023.
  • Armistice Capital's portfolio value rose 12% quarter-over-quarter to $7.33B.

Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.